Sanofi donates health emergency kits, tetanus vaccines, and essential medicines to address humanitarian needs

Support from the Sanofi Espoir Foundation and collaboration with the Ministry for Europe and Foreign Affairs, Tulipe Association, UNICEF and the French Embassy

Sanofi donates health emergency kits, tetanus vaccines, and essential medicines to address humanitarian needs
  • Nearly four metric tons of medical products transported
  • Sanofi's medicines and vaccines account for half of this donation.
  • Supplies to be distributed to local hospitals to address health emergencies and urgent medical needs

BEIRUT: Following the massive explosions that overwhelmed Beirut, Sanofi and “Sanofi Espoir” foundation, will provide health and medical assistance to hospitals in the city and nearby suburbs, aiding as much as possible the thousands of victims. The efforts will be coordinated with the Ministry of Public Health and UNICEF.

In support of these efforts, Sanofi and its partners swiftly sent approximately four tons of medical aid, including 48 emergency health kits provided by Tulipe Association, and 10,000 doses of tetanus vaccines, which are needed in large quantities given its prophylactic use in those who were injured.

Two tons of essential medicines are being distributed to address health emergencies and medical needs. The essential medicines include antibiotics, anti-inflammatory, and anti-thrombotic medications.

The emergency health kits are used to treat the wounded and injured as well as help to  meet the basic health care needs of displaced and affected people who do not have access to medical facilities. The kits, in accordance with WHO recommendations, include medicines, medical supplies, and basic medical equipment. Each of the 48 health emergency kits provided by Sanofi provides care for approximately 10,000 people for a three month period. The kits contain:

  • Basic equipment for steam sterilization to sterilize facilities of all environmental types.
  • Medicines for treatment of acute severe hypertension, acute coronary syndrome, acute stroke and acute heart failure insulin syringes, as well as pediatric medications, and asthma and acute chronic obstructive pulmonary disease (COPD) treatment devices.
  • Surgical sutures and medical bandages.

In cooperation with a number of French agencies headed by the French Ministry for Europe and Foreign Affairs, the Crisis and Support Center of the Ministry for Europe and Foreign Affairs, and the French Embassy in Lebanon, Sanofi was able to ship the supplies to Lebanon using the French authorities planes.

In coordination with the French Embassy, the emergency health kits will be distributed to Lebanese hospitals, healthcare centers, and civil societies that aid and treat the injured.Coordination is also being made with UNICEF and the Lebanese Ministry of Public Health to facilitate the distribution of tetanus vaccines and essential medicines.

Sanofi is committed to assisting the Lebanese community in coping with this difficult sitatuion, and will continue to work with the Ministry of Public Health to provide medical solutions, important medicines, and treatments.

About Sanofi

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life

Media Relations Contact
Hanan Katerji
Position: Head of Communications Levant

Send us your press releases to

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases